GOVERNMENT UNIVERSITY INDUSTRY RESEARCH ROUNDTABLE (GUIRR) AND THE FEDERAL DEMONSTRATION PARTNERSHIP (FDP)

阿尔茨海默病 背景 包括美国国立卫生研究院在内的联邦科学机构需要对联邦政府、大学和产业界之间的伙伴关系中出现的紧迫问题进行持续和积极的审查，以便有效地确定阻碍科学创新和在全球市场上竞争的障碍。其中许多问题与环境和这些不同部门之间的关系有关，这些部门对科学思想的进步和这些思想从实验室到实践的转变有很大的影响。在这个国家，大学和联邦政府之间的关系在上个世纪中叶由万尼瓦尔·布什在他的远见卓识的著作《科学无尽的前沿》中描述。他指出，我们国家的安全、健康和进步不仅取决于联邦政府和大学之间关系的强弱，还取决于这些部门与将这些进步带入生产的行业之间的关系。 GUIRR成立于1984年，是为了响应国家研究委员会的报告，该报告呼吁建立一个制度化的论坛，以加强政府和非政府研究组织的最高领导人之间的沟通。GUIRR的正式目标是：召集来自政府、大学和行业的最高层代表，定义和探讨与国家和全球科学技术议程相关的共同感兴趣的关键问题；制定当前辩论和分析产生的下一个关键问题的框架；并孵化对利益攸关方具有持续价值的活动。该论坛旨在促进与会者之间的坦诚对话，促进自我实施活动，并酌情向更广泛的公众传播对后果的认识。最终，目标是提高国家科学事业的质量、内容和生产率。 摘要 GUIRR将发布一份关于其活动的年度报告，说明GUIRR对现代科学事业的影响、GUIRR成员与现代科学事业的相关性、招募成员以更好地反映现代科学事业的多样性的努力、网络研讨会出席情况以及为增加出席人数所做的努力，并应要求向NIH工作组负责人和候补及其他NIH工作人员提供关于FDP的信息。自民党每年将至少举行三次会议，并根据要求向国家卫生研究院的任务负责人和候补人员以及其他国家卫生研究院工作人员发布会议摘要。 FDP将参与与联邦研究机构和学术界之间的关系有关的活动和项目。如果公开发布的工作成果被禁运，应在公开发布前不少于48小时将其分发给上述NIH工作人员，即基本合同SOW，第3页。PGA应在邮寄或通过电子邮件发送禁运副本后通知上述NIH工作人员。如果没有被禁运，NAS应在公开发布当天向上面列出的NIH工作人员分发。 阿尔茨海默病

Alzheimer's disease Background The federal science agencies including the NIH require a continuous and proactive examination of pressing issues that arise within the partnership between the federal government, universities, and industry in order to effectively identify barriers to scientific innovation and competiveness in the global marketplace. Many of these issues relate to the environment and the relationships between these different sectors that strongly influence the advancement of scientific ideas and the transition of those ideas from the lab to practice. In this country, the relationship between universities and the federal government was described in the middle of the last century by Vannevar Bush in his visionary work, Science the Endless Frontier. He makes the point that the security, the health, and the advancement of our nation is dependent on the strength of the relationship not only between the federal government and the universities but also the relationship of those sectors to the industry that brings those advancements into production. GUIRR was created in 1984 in response to the report of the National Commission on Research, which called for an institutionalized forum to enhance communication among the top leaders of government and non-government research organizations. GUIRR's formal objective is: to convene senior-most representatives from government, universities, and industry to define and explore critical issues related to the national and global science and technology agenda that are of shared interest; to frame the next critical question stemming from current debate and analysis; and to incubate activities of on-going value to the stakeholders. The forum is designed to facilitate candid dialogue among attendees, to foster self-implementing activities, and, where appropriate, to carry awareness of consequences to the wider public. Ultimately, the goal is to improve the quality, content, and productivity of the national science enterprise. Abstract GUIRR will publish an annual report on its activities describing GUIRR's impacts on the modern science enterprise, the relevance of GUIRR membership to the modern science enterprise, efforts to recruit members to better reflect the diversity of the modern science enterprise, webinar attendance, and efforts to increase attendance and include information about FDP to the NIH Task Leaders and Alternate and other NIH staff by request. FDP will hold at least three meetings per year and issue meeting summaries to the NIH Task Leader and Alternate and to other NIH staff by request. FDP will engage in activities and projects related to the relationship between federal research agencies and the academic community. If a publicly released work product is embargoed, it shall be distributed to the NIH staff listed above no less than 48 hours in advance of the public release, IAW the Basic Contract SOW, page 3. PGA shall notify the NIH staff listed above when embargoed copies have been mailed or emailed as applicable. If not embargoed, NAS shall distribute to the NIH staff listed above on the day of public release. Alzheimer's disease